Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay

Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay

Cecilia Castillo,1 Natalia Camejo,1 Monika Rondan,1 Florencia Savio,1 Guadalupe Herrera,2 Gabriel Krygier,1 Lucia Delgado1 1Department of Clinical Oncology, School of Medicine, University of Uruguay, Montevideo, Uruguay; 2Department of Quantitative Methods, School of Medicine, University of Uruguay,...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Castillo C, Camejo N, Rondan M, Savio F, Herrera G, Krygier G, Delgado L
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Dove Medical Press 2021-12-01
Σειρά:	Breast Cancer: Targets and Therapy
Θέματα:	time adjuvant chemotherapy breast cancer survival
Διαθέσιμο Online:	https://www.dovepress.com/survival-and-time-to-initiation-of-adjuvant-chemotherapy-among-breast--peer-reviewed-fulltext-article-BCTT

Παρόμοια τεκμήρια

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening
ανά: Irene Zarcos‐Pedrinaci, κ.ά.
Έκδοση: (2019-11-01)

Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
ανά: Hai-Fei Niu, κ.ά.
Έκδοση: (2016-03-01)

Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study
ανά: Zeleke Alem A, κ.ά.
Έκδοση: (2020-09-01)

Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases
ανά: Lin-Yu Xia, κ.ά.
Έκδοση: (2020-06-01)

Trends in Adjuvant Chemotherapy Use in Endocrine-Sensitive, HER-2 Negative Breast Cancer, With 1 to 3 Positive Nodes: A Single-Centre Study
ανά: José Manuel Baena Cañada, κ.ά.
Έκδοση: (2021-07-01)

The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis
ανά: Xingfa Huo, κ.ά.
Έκδοση: (2021-01-01)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
ανά: Bhaskar C. Kolla, κ.ά.
Έκδοση: (2020-05-01)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
ανά: Mok-Won Lee, κ.ά.
Έκδοση: (2021-02-01)

Does the breast reconstruction method have an impact on time delay to adjuvant chemotherapy – A comparison between autologous and expander/implant breast reconstruction
ανά: Monika Lanthaler, κ.ά.
Έκδοση: (2022-09-01)

Dynamic Changes of Blood Lipids in Breast Cancer Patients After (Neo)adjuvant Chemotherapy: A Retrospective Observational Study
ανά: Xu L, κ.ά.
Έκδοση: (2020-10-01)

To Evaluate the Changes Arise in the Parameters of Liver and Kidney during Adjuvant Chemotherapy in Breast Cancer Patients
ανά: Hina Akbar Memon, κ.ά.
Έκδοση: (2021-01-01)

The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
ανά: Wen-Fen Fu, κ.ά.
Έκδοση: (2020-09-01)

Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy
ανά: Xin Li, κ.ά.
Έκδοση: (2018-04-01)

Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
ανά: Hasan Jalaeikhoo, κ.ά.
Έκδοση: (2019-01-01)

The Effects of Different Induction Chemotherapy Cycles and Adjuvant Chemotherapy on the Survival Outcomes of Patients With Locally Advanced Nasopharyngeal Carcinoma
ανά: Shu Liao, κ.ά.
Έκδοση: (2022-06-01)

Impact of adjuvant chemotherapy on relapse-free survival of patients with locally advanced cervical cancer
ανά: M. P. Smirnova, κ.ά.
Έκδοση: (2022-01-01)

The Impact of Neo-adjuvant and Adjuvant Chemotherapy in Treatment Outcome of Patients with High Risk Soft Tissue Sarcomas of the Extremities
ανά: Rasha Hamdy Hamed, κ.ά.
Έκδοση: (2012-04-01)

INTRA-ATERIAL CHEMOTHERAPY OF THE BREAST CANCER
ανά: Shamil Kh. Gantsev, κ.ά.
Έκδοση: (2017-09-01)

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
ανά: Shuogui Fang, κ.ά.
Έκδοση: (2023-02-01)

The Impact of Colon Cancer Sites on Survival Rates after Curative Resection and Adjuvant Chemotherapy: A SingleCenter Study
ανά: Sureerat Jaruhathai, κ.ά.
Έκδοση: (2022-10-01)

Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
ανά: Bin Huang, κ.ά.
Έκδοση: (2021-11-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
ανά: L. V. Bolotina, κ.ά.
Έκδοση: (2014-07-01)

Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis
ανά: Nickolas Stabellini, κ.ά.
Έκδοση: (2023-04-01)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
ανά: Jianping Guo, κ.ά.
Έκδοση: (2023-10-01)

Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study
ανά: Pengfei Su, κ.ά.
Έκδοση: (2023-10-01)

Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
ανά: Serhat Sekmek, κ.ά.
Έκδοση: (2023-11-01)

Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010–2016
ανά: Thomas M. Schwedhelm, κ.ά.
Έκδοση: (2020-09-01)

Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study
ανά: Jida Chen, κ.ά.
Έκδοση: (2023-01-01)

Taxanes in adjuvant and neoadjuvant therapy for breast cancer
ανά: S. V. Limareva
Έκδοση: (2014-08-01)

RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients
ανά: Haibo Wang, κ.ά.
Έκδοση: (2022-12-01)

Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study
ανά: Lei Chen, κ.ά.
Έκδοση: (2021-08-01)

Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis
ανά: Hariyono Winarto, κ.ά.
Έκδοση: (2022-11-01)

Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
ανά: Qiusheng Guo, κ.ά.
Έκδοση: (2023-05-01)

Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based study
ανά: Elizabeth Alwers, κ.ά.
Έκδοση: (2020-02-01)

Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components
ανά: Rongyang Li, κ.ά.
Έκδοση: (2024-01-01)

Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer
ανά: Denis Ganenko, κ.ά.
Έκδοση: (2019-01-01)

Selecting chemotherapy schedules for adjuvant treatment of early stage breast cancer, what is the rationale behind?
ανά: Roham Salek, κ.ά.
Έκδοση: (2015-07-01)

Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A National Cancer Database analysis
ανά: Nickolas Stabellini, κ.ά.
Έκδοση: (2023-10-01)

Response Rate to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer Based on Common Molecular Receptors
ανά: Abdolreza Fazel, κ.ά.
Έκδοση: (2024-10-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
ανά: Yu. S. Shatova, κ.ά.
Έκδοση: (2017-12-01)